Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV open-label single-arm study of dimethyl fumarate enteric capsules in relapsing multiple sclerosis
CTR20253074Phase 4Active
- Sponsor
- Qilu Pharmaceutical
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dimethyl fumarate in multiple sclerosis (MS), sponsored by Qilu Pharmaceutical. Started Nov 2025; status: active.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on CTR20253074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253074.